Bruce I Sachs Receives Stock Award at Vertex Pharmaceuticals Inc MA (VRTX) — SEC Form 4, Jul 17, 2026
SEC Form 4 · No Market Transaction
Stock Award
Compensation grant — no market purchase or sale.
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Vertex Pharmaceuticals Inc MA
VRTX
CIK 0000875320
All Vertex Pharmaceuticals Inc MA insider activity
Reporting Owner
| Name | Relationship |
|---|---|
| Bruce I Sachs CIK 0001197036 |
Director
|
Bruce I Sachs at Vertex Pharmaceuticals Inc MA
Full insider history
Bought (12 mo)
—
Sold (12 mo)
—
More from this insider at Vertex Pharmaceuticals Inc MA
| 2026-10-19 | Award | — | View |
| 2026-08-31 | Gift/Other | — | View |
| 2026-05-05 | Award | — | View |
| 2026-04-17 | Award | — | View |
| 2026-01-20 | Award | — | View |
Derivative Securities Transactions
Footnotes (1)
- F1
- Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death. Show more
Related filings at Vertex Pharmaceuticals Inc MA
Institutional Holders
13F holders · Jun 30, 2026
1,768
institutional managers reporting a position
Largest by reported value
- Capital World Investors $13B
- Black Rock, Inc. $12B
- Capital Research Global Investors $9.68B
5%+ Holders · 13D/G
3 filers
Other insiders at Vertex Pharmaceuticals Inc MA
GET /v1/forms/4/0000875320-26-000249
API docs
View Original SEC Filing